Tumor Necrosis Factor (TNF) inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tumor Necrosis Factor (TNF) inhibitors, covering 2018-07-26 to 2018-07-26. Get the full timeline:
Most recent: Clinical Trial Update: A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.